Gérard Sommé

Strategic Account Director & Country Manager, Omnicare Clinical Research

95TavernyIle-de-France - France

4 contacts
Expérience professionnelle
2003 - 2009

Strategic Account Director: Since August 2007.
Country Manager: Since August 2005.
Senior Account Director: Since January 2005
Account Director: Since August 2003

Industrie Pharmaceutique
2001 - 2003

Set-up of the French Affiliate, Business Development, Management and Administration, Clinical Operations, Regulatory Affairs

Industrie Pharmaceutique
1999 - 2001

Set-up of the French subsidiary, business development, management and administration, operations, logistics

Industrie Pharmaceutique
1997 - 1999

Set up of the company, Business Development, Management and Administration, Operations, Quality Assurance, Logistics and Shipments

Industrie Pharmaceutique
1995 - 1997

Management of the R&D department and of the manufacturing unit. Set up of ISO 9001 certification, AFSSAPS and FDA submissions.

Biotechnologie
1985 - 1995

Scientific Director: Member of the Board, relationships with investors, technology transfers from universities and research organisations, licenses and patents, contacts with biotech partners (USA) and distributors (France, Europe, USA). Management of R&D, regulatory affairs, and manufacturing (50 employees).

Biotechnologie
1976 - 1985

BFundamental Research, Biochemistry, Immunology and Genetic Engineering

Enseignement - Animation - Recherche
Ancien élève de
Communauté
UPMC
6273 membres

Les visiteurs de ce profil ont aussi consulté
Fatima EL GHAIB
Clinical Research Associate (CRA)
Philibert Martig
Ingénieur, N/A
Aundreane Bidi
Etudiant, institut Rouseau
Thomas Beaurain
Etudiant, Université Paris Dauphine
Abdelaziz FAHEM
Experimented Medical Science Liaison - Medical Device - Oncology
Grégory Baret
Poseur Photovoltaique, Isicom Services
MARIE TOMAS MISSIOUX
Collaboratrice, ACVU
Lucie Poncet
Directeur generale, mbd plast
Benedicte Charpy
Project Manager, ICON Clinical Research
Anne Bouchet
Senior Director Business Development, Nuvisan Oncology